Growth Factors (Blood And Tissue) - A World Report : Market Research Report

Growth Factors (Blood And Tissue) - A World Report

Published: Nov. 1, 2009 - 378 Pages

1. METHODOLOGY: Study Reliability and Reporting Limitations; Disclaimers; Quantitative Techniques & Reporting Level
2. INTRODUCTION: Growth Factors: A Preface; Growth Factors: Their Role and Related Applications; Growth Factors: Adding a New Dimension; Growth Factors: Classification Based on Activity; Recent Trends & Developments; Recombinant Human Erythropoietin: Gradually Gaining Dominance
3. MARKET OVERVIEW: EPO - The Lead ‘Factor’
4. MARKET DYNAMICS: Dethroning the Leaders; Expiration of Patents Fuels Competition and Sales; India - At the Center Stage…; Side Effects - Still a Concern…; CDER- A Regulatory Review Authority for Growth Factors
5. OUTLOOK: Innovative Delivery System Shows Potential for Accelerating Use of Growth Factors; Cytokines - Vital Growth Propellers for the Future of New Drugs; Brain Derived Neurotrophic Factor (BDNF) Finds Increased Application; Age-Related Diseases - Their Influence on Effective Therapies; Copaxone Finds Novel Applications; Mimetic Growth Factors - Exhibiting Promising Potential
6. INDUSTRY ISSUES: Development of Cost Effective Methods - Need of the Hour; Influence of Neurotrophic Factors on Brain Cell Development; Combination of Interferons and Ribavirin Develops More Anemia Cases
7. COMPETITIVE TRENDS: RegeneRx Focuses on Wound Healing Market; DRL Introduces a Program to Propel its Biogenerics Business
8. PRODUCT FACTS: Blood Growth Factors; Tissue Growth Factors
9. RESEARCH AND DEVELOPMENT HIGHLIGHTS: Maxygen Updates on Factor VII Program; Evaluation of Extended Dosing Schedule of PROCRIT®; Nerve Growth Factor Shows Promising Potential Against Diabetes; Cytokines and GM-CSF Found to be Closely Interlinked; GM-CSF Enhances Rate of Survival in Neonates; rG-CSF Well Tolerated in Pneumonia and Severe Sepsis Patients; rG-CSF- Their Influence on Preterm Infants with Sepsis; Serum Macrophage Colony Stimulating Growth Factors Associated with Thrombocyte and Monocyte; Src Pathway Inactivation in Kit Impairs Blood Cell Growth and Proliferation; Cole Eye Institute Offers TIMP-3 Mechanism for Preventing Abnormal Growth of Blood Vessels; Effect of Brain Derived Neurotrophic Factor on Retinal Cells; Orcel™ Exhibits High Growth Factor for Wound Healing and Cardiovascular Applications; Drug Combination of Macrophage Colony Stimulating Factor Shows Successful Tolerance Levels; Neotrofin™ Triggers Neurotrophic Factors; G-CSF Shows Capability for Promoting Neutrophil Production; Insulin-like Growth Factor-1 (IGF) Gene Transfer Accelerates Wound Healing Process; Hepatocyte Growth Factors - Exhibiting Dual Role; Cortex Pharmaceuticals Ampakines® Promotes Expression of Neurotrophin; Granulocyte Colony Stimulating Factor Finds Application in Treating Neonates; Cerebrolysin Promotes Cognition
10. BREAKTHROUGHS - A REVIEW: Novel Set of Human Cytokines Unveiled; IGFBP-3 and its Potential to Ward Off Gastric Cancer; Bone Morphogenic Proteins Show Potential for Musculoskeletal Regeneration; Growth Factors - Their Role in Preventing Heart Stroke; Growth Factor Proteins Shows Promising Results for Treating Cancer; Neurotrophic Growth Factor Primarily Responsible for Loss of Vision; Redox-Active Grape Seed Exhibits Favorable Properties for Dermal Wound Healing; Role of Brain-Derived Neurotrophic Factor on Memory; Nerve Growth Factor Found to Enhance Barium Current and Insulin Secretion; Lipid Peroxidation May be Associated with Wound Healing; Genentech Inc Unveils Molecule for Stimulating Growth of Blood Vessels; Connective Tissue Growth Factor Found to Promote Lung Fibroblast; Influence of Insulin-Like Growth Factor on Growth; Regeneron Discovers Angiopoietins Targeted at Blood Vessel Growth and Repair; Environment and Insulin-Like Growth Factors Stimulate Risk of Cancer; Cocktail of Neurotrophic Factors Promotes Regeneration of Torn Nerves; Growth Factors Administration to Stimulate Tissue Repair; Cytokine - Their Role in Combating Hepatitis C Virus; Axokine® Yields Favorable Results Against Obesity; Cell Genesys Unveils GDNF Gene Therapy Targeted Against Parkinson’s Disease
11. CORPORATE DEVELOPMENTS: Pfizer Inks Exclusive Global Licensing Agreement with Scil Technology; ZGEN Initiates Ph II Trial of Interleukin 21; FzioMed Bags Health Canada Approval on Oxiplex®; NsGene A/S Implants Encapsulated Cell in Patients; Reliance Life Sciences Takes Over Genemedix; Fraunhofer Institute Introduces First Interferon Beta 1a to Treat Multiple Sclerosis; Shanghai Wanxing Inks Export Deal for Recombinant Human Interferon; Hemispherx Enters into Distribution Agreement with Armada; Bayer Launches US Pharmaceuticals Subsidiary; Merck Inks Agreement with Bristol-Myers Squibb and ImClone; CoGenesys Signs Global Licensing Agreement with Vegenics; InterMune Inks New Supply Deal with Boehringer Ingelheim; Boston Life Sciences Adopts New Name of Alseres Pharmaceuticals; Cambrex Divests Bioproducts and Biopharma Subsidiaries; Dragon Divests EPO Business; Caregene and Genzyme Forms Partnership to Develop Cere-120; Amgen Bags EC Approval on Use of Aranesp(R) in Paediatric Patients; NsGene to Undertake Phase Ib Clinical Trial of NsG0202; Roche Receives European Approval for NeoRecormon; Bolder Receives Two U.S. Patents for Hematopoietic Factors; Hospira Receives EC Approval on Retacrit; RLS to Initiate Clinical Trials of Erythropoietin; InterMune Drops Phase III trial of Interferon; Chugai to Conduct Additional Trial on Epogin®
12. MAJOR PLAYERS: Amgen, Inc. (USA); BioMimetic Therapeutics, Inc. (USA); Biopharm GmbH (Germany); Bolder Biotechnology, Inc. (USA); Alseres Pharmaceuticals, Inc. (USA); Ceregene, Inc. (USA); FibroGen, Inc. (USA); FzioMed, Inc. (USA); Insmed, Inc. (USA); Johnson & Johnson (USA); Lonza Group (Switzerland); Maxygen, Inc. (USA); Merck Serono International S.A. (Switzerland); NsGene A/S (Denmark); PeproTech, Inc. (USA); Rentschler Biotechnologie GmbH (Germany); F. Hoffmann-La Roche Ltd (Switzerland); Shantha Biotechnics (India); Scil Proteins GmbH (Germany); Wockhardt Ltd. (India)
13. MARKET ANALYTICS
14. THE UNITED STATES: EPO Market Scenario
15. JAPAN: Erythropoietin Market: Competitive Scenario; Market Scenario for Biotech Products; Biotech Market Backed by Public Assistance
16. EUROPE
17. REST OF WORLD: An Overview of Indian Market; Table 1: Global Growth Factors (Blood and Tissue) Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 2: Percentage Breakdown of Global Growth Factors (Blood and Tissue) Market by Region for the Years 2008 & 2012; Table 3: Global Blood Growth Factors Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 4: Percentage Breakdown of Global Blood Growth Factors Market by Region for the Years 2008 & 2012; Table 5: Global Blood Growth Factors Market by Type for the Period 2007-2015 (Sales in US$ Million); Table 6: Percentage Breakdown of Global Blood Growth Factors Market by Type for the Years 2008 & 2012; Table 7: Global Erythropoietins Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 8: Percentage Breakdown of Global Erythropoietins Market by Region for the Years 2008 & 2012; Table 9: Global Colony Stimulating Factors Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 10: Percentage Breakdown of Global Colony Stimulating Factors Market by Region for the Years 2008 & 2012; Table 11: Global Interferons Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 12: Percentage Breakdown of Global Interferons Market by Region for the Years 2008 & 2012; Table 13: Global Interleukins Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 14: Percentage Breakdown of Global Interleukins Market by Region for the Years 2008 & 2012; Table 15: Global Tissue Growth Factors Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 16: Percentage Breakdown of Global Tissue Growth Factors Market by Region for the Years 2008 & 2012; Table 17: Growth Factors (Blood and Tissue) Market by Type in the US: 2007-2015 (Sales in US$ Million); Table 18: Percentage Breakdown of Growth Factors (Blood and Tissue) Market by Type in the US for the Years 2008 & 2012; Table 19: Growth Factors (Blood and Tissue) Market by Type in Japan: 2007-2015 (Sales in US$ Million); Table 20: Percentage Breakdown of Growth Factors (Blood and Tissue) Market by Type in Japan for the Years 2008 & 2012; Table 21: Growth Factors (Blood and Tissue) Market by Type in Europe: 2007-2015 (Sales in US$ Million); Table 22: Percentage Breakdown of Growth Factors (Blood and Tissue) Market by Type in Europe for the Years 2008 & 2012; Table 23: Growth Factors (Blood and Tissue) Market by Type in the Rest of World: 2007-2015 (Sales in US$ Million); Table 24: Percentage Breakdown of Growth Factors (Blood and Tissue) Market by Type in the Rest of World for the Years 2008 & 2012
COMPANIES PROFILED

Abstract

Age-related conditions such as Alzheimer's disease, malignancies, trauma and autoimmune disorders necessitate the development of less-invasive and more effective therapies. Growth factors (blood and tissue) have made an indelible mark on the market as a promising and cost-effective therapeutic solution for addressing unmet medical needs. Growth factors have a wide range of opportunities, especially in treating critical conditions such as granulocytopenia, leukemia, aplastic anaemia, bone marrow transplantation, and myelodysplastic syndrome. Additionally, human recombinant technologies have triggered these therapeutic biological products to greater heights.

These and other market data and trends are presented in "Growth Factors ( Blood And Tissue ): A World Report" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

2/15/2012 - 32

Growth Factors (Blood And Tissue) - A World Report

Table of Contents

Abstract